Archive - Ion Genomics

Mitochondria: The Genome’s Better Half, With Gordon Freedman

Gordon Freedman has already made a movie about Steven Hawking’s physics. The mystery behind mitochondria could be next, but there’s still lots of…

Sep 11 • Andrew P. Han

50:52

Google Predicts Genetic Impacts Everywhere in New AlphaGenome Atlas: Newsletter Sept. 9, 2026

Ultima Genomics partners with Nvidia on large-scale pangenome analysis, FDA approves a longitudinal liquid biopsy companion diagnostic, and more.

Sep 9 • Andrew P. Han

Ultima Genomics, Nvidia Partner on Pangenome-Aware WGS Analysis

The collaboration will use Google’s DeepVariant to try to make pangenome-aware variant calling practical for population-scale sequencing programs.

Sep 9 • Andrew P. Han

FDA Approves Longitudinal Use of Guardant360 CDx with AstraZeneca Breast Cancer Drug

Guardant360 CDx will be the first liquid biopsy companion diagnostic to be approved for repeat testing — every three months.

Sep 8 • Andrew P. Han

Who Did Tempus AI Beat Out to Acquire Personalis? Newsletter, Sept. 2, 2026

10x Genomics Wins Patent Infringement Trial, George Church’s new AI in bio startup, a new multiomic spatial method in tissue, and more.

Sep 2 • Andrew P. Han

Germany’s Heidelberg Epignostix Partners With UK NHS on Brain Tumor Methylation Testing

The deal brings epigenetics-based CNS tumor classification to NHS labs, with free pediatric testing for three years.

Sep 2 • Andrew P. Han

Guardant's Shield Colorectal Cancer Screening Test Gains Coverage From Carelon

The policy update means approximately 90 million Americans now have a path to insurance coverage of the colorectal cancer screening test.

Sep 1 • Andrew P. Han

August 2026

Natera to Sponsor Breast Cancer Awareness 5Ks, Adds Angiex ADC Trial Collaboration

Natera will be a top sponsor for the “Race for the Cure” events and, separately, collaborate with Angiex on an antibody-drug conjugate trial.

Aug 28 • Andrew P. Han

10x Genomics Wins $4.8M Infringement Verdict Against Parse Biosciences, Will Seek Injunction

10x said it plans to seek a permanent injunction against sales of Parse’s single-cell products in the US, as well as additional monetary penalties.

Aug 28 • Andrew P. Han

Biotech Investor Vinod Khosla Adds NFL Team to Portfolio

One of the world’s most exclusive clubs voted in the Khosla family as controlling owners of the Seattle Seahawks, the defending Super Bowl champions.

Aug 27 • Andrew P. Han

How George Church’s New AI in Biology Startup Plans to Spend $20M

Astromech, a spinout from Colossal Biosciences, plans to mine animal genomics with AI to learn more about longevity.

Aug 27 • Andrew P. Han

Edited Antibody Images Aren't Just Thermo Fisher's Problem: Newsletter Aug. 26, 2026

10x Genomics and Parse go to trial, Guardant appeals $243M legal bill, investors respond to Twist’s Anthropic collab reveal, MGI reports financials, and…

Aug 26 • Andrew P. Han

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts